Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACA PRKACB PRKACG PRKG2 PRKX PRKY	2.38e-12	9	113	6	GO:0004690
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACA PRKACB PRKACG PRKX PRKY	1.10e-10	7	113	5	GO:0004691
GeneOntologyMolecularFunction	heparan sulfate 6-O-sulfotransferase activity	HS6ST2 HS6ST1 HS6ST3	1.76e-07	3	113	3	GO:0017095
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACA PRKACB PRKACG	2.06e-05	10	113	3	GO:0004679
GeneOntologyMolecularFunction	prostaglandin-endoperoxide synthase activity	PTGS1 PTGS2	3.17e-05	2	113	2	GO:0004666
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	PGA4 PGA5 CTSE PGA3	5.56e-05	37	113	4	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	PGA4 PGA5 CTSE PGA3	6.19e-05	38	113	4	GO:0070001
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	HS6ST2 HS6ST1 HS6ST3	7.64e-05	15	113	3	GO:0034483
GeneOntologyMolecularFunction	protein kinase activity	PDK2 SPEG MST1 PRKACA PRKACB PRKACG FES IRAK3 PRKG2 PRKX PRKY	5.99e-04	600	113	11	GO:0004672
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	PDK2 SPEG PRKACA PRKACB PRKACG IRAK3 PRKG2 PRKX PRKY	9.82e-04	446	113	9	GO:0004674
GeneOntologyBiologicalProcess	protein kinase A signaling	PRKACA PRKACB PRKACG PRKG2 PRKX PRKY	2.05e-07	48	110	6	GO:0010737
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process, enzymatic modification	HS6ST2 HS6ST1 HS6ST3	3.14e-05	12	110	3	GO:0015015
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process	HS6ST2 EXTL3 HS6ST1 HS6ST3	3.53e-05	35	110	4	GO:0015012
GeneOntologyBiologicalProcess	high-density lipoprotein particle assembly	PRKACA PRKACB PRKACG	4.06e-05	13	110	3	GO:0034380
GeneOntologyBiologicalProcess	regulation of postsynaptic neurotransmitter receptor activity	SHISA7 CHRNA5 NOTCH1	9.50e-05	17	110	3	GO:0098962
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan metabolic process	HS6ST2 HS6ST1 HS6ST3	9.50e-05	17	110	3	GO:0030201
GeneOntologyCellularComponent	multivesicular body lumen	PGA4 PGA5 PGA3	5.44e-06	7	114	3	GO:0097486
GeneOntologyCellularComponent	cAMP-dependent protein kinase complex	PRKACA PRKACB PRKACG	1.84e-05	10	114	3	GO:0005952
GeneOntologyCellularComponent	late endosome lumen	PGA4 PGA5 PGA3	2.52e-05	11	114	3	GO:0031906
GeneOntologyCellularComponent	cholinergic synapse	CHRNA4 CHRNA5 SLC22A2	2.26e-04	22	114	3	GO:0098981
Domain	Peptidase_aspartic_dom	PGA4 PGA5 RTL1 CTSE PGA3	3.61e-08	17	109	5	IPR021109
Domain	Aspartic_peptidase_N	PGA4 PGA5 CTSE PGA3	3.79e-08	7	109	4	IPR012848
Domain	A1_Propeptide	PGA4 PGA5 CTSE PGA3	3.79e-08	7	109	4	PF07966
Domain	IGc2	HSPG2 IGFN1 VSIG2 PSG4 SPEG SIGLEC5 NCAM2 HMCN2 SIGLEC10 NECTIN4 GPA33	1.29e-07	235	109	11	SM00408
Domain	Ig_sub2	HSPG2 IGFN1 VSIG2 PSG4 SPEG SIGLEC5 NCAM2 HMCN2 SIGLEC10 NECTIN4 GPA33	1.29e-07	235	109	11	IPR003598
Domain	Heparan_SO4-6-sulfoTrfase	HS6ST2 HS6ST1 HS6ST3	1.93e-07	3	109	3	IPR010635
Domain	Aspartic_peptidase_A1	PGA4 PGA5 CTSE PGA3	2.24e-07	10	109	4	IPR001461
Domain	PEPTIDASE_A1	PGA4 PGA5 CTSE PGA3	2.24e-07	10	109	4	IPR033121
Domain	Asp	PGA4 PGA5 CTSE PGA3	2.24e-07	10	109	4	PF00026
Domain	PEPTIDASE_A1	PGA4 PGA5 CTSE PGA3	2.24e-07	10	109	4	PS51767
Domain	Ig_V-set	HSPG2 VSIG2 PSG4 SIGLEC5 NCAM2 PTGFRN BTN1A1 SIGLEC10 NECTIN4 GPA33	2.57e-07	199	109	10	IPR013106
Domain	-	PGA4 PGA5 CTSE PGA3	5.24e-07	12	109	4	2.40.70.10
Domain	ASP_PROTEASE	PGA4 PGA5 CTSE PGA3	5.24e-07	12	109	4	PS00141
Domain	Aspartic_peptidase_AS	PGA4 PGA5 CTSE PGA3	7.54e-07	13	109	4	IPR001969
Domain	IG	HSPG2 IGFN1 VSIG2 PSG4 SPEG SIGLEC5 NCAM2 PTGFRN HMCN2 BTN1A1 SIGLEC10 NECTIN4 GPA33	1.06e-06	421	109	13	SM00409
Domain	Ig_sub	HSPG2 IGFN1 VSIG2 PSG4 SPEG SIGLEC5 NCAM2 PTGFRN HMCN2 BTN1A1 SIGLEC10 NECTIN4 GPA33	1.06e-06	421	109	13	IPR003599
Domain	V-set	HSPG2 VSIG2 PSG4 SIGLEC5 PTGFRN BTN1A1 SIGLEC10 NECTIN4 GPA33	1.31e-06	184	109	9	PF07686
Domain	Ig-like_dom	HSPG2 IGFN1 VSIG2 PTCRA PSG4 SPEG SIGLEC5 NCAM2 PTGFRN HMCN2 BTN1A1 SIGLEC10 NECTIN4 GPA33	1.36e-06	503	109	14	IPR007110
Domain	IGv	HSPG2 VSIG2 NCAM2 PTGFRN BTN1A1 GPA33	4.99e-06	75	109	6	SM00406
Domain	IG_LIKE	HSPG2 IGFN1 VSIG2 PSG4 SPEG SIGLEC5 NCAM2 PTGFRN HMCN2 BTN1A1 SIGLEC10 NECTIN4 GPA33	5.74e-06	491	109	13	PS50835
Domain	Ig-like_fold	HSPG2 IGFN1 VSIG2 PTCRA PSG4 SPEG SIGLEC5 NCAM2 PTGFRN HMCN2 BTN1A1 SIGLEC10 PKHD1 NECTIN4 GPA33	1.49e-05	706	109	15	IPR013783
Domain	ig	HSPG2 PSG4 SIGLEC5 NCAM2 PTGFRN SIGLEC10 NECTIN4 GPA33	1.57e-05	190	109	8	PF00047
Domain	Immunoglobulin	HSPG2 PSG4 SIGLEC5 NCAM2 PTGFRN SIGLEC10 NECTIN4 GPA33	1.57e-05	190	109	8	IPR013151
Domain	AGC-kinase_C	PRKACA PRKACB PRKACG PRKG2 PRKX	1.86e-05	56	109	5	IPR000961
Domain	AGC_KINASE_CTER	PRKACA PRKACB PRKACG PRKG2 PRKX	1.86e-05	56	109	5	PS51285
Domain	S_TK_X	PRKACA PRKACB PRKACG PRKG2 PRKX	1.86e-05	56	109	5	SM00133
Domain	EGF_LAM_2	HSPG2 LAMC3 NTN4 ATRNL1	2.68e-05	30	109	4	PS50027
Domain	EGF_LAM_1	HSPG2 LAMC3 NTN4 ATRNL1	2.68e-05	30	109	4	PS01248
Domain	-	HSPG2 IGFN1 VSIG2 PTCRA PSG4 SPEG SIGLEC5 NCAM2 PTGFRN BTN1A1 SIGLEC10 PKHD1 NECTIN4 GPA33	3.14e-05	663	109	14	2.60.40.10
Domain	Prothrombin/thrombin	F2 MST1	3.37e-05	2	109	2	IPR003966
Domain	HGF-like	HGF MST1	3.37e-05	2	109	2	IPR024174
Domain	Sulfotransfer_2	HS6ST2 HS6ST1 HS6ST3	4.09e-05	12	109	3	PF03567
Domain	Sulfotransferase	HS6ST2 HS6ST1 HS6ST3	4.09e-05	12	109	3	IPR005331
Domain	EGF_Lam	HSPG2 LAMC3 NTN4 ATRNL1	5.00e-05	35	109	4	SM00180
Domain	Laminin_EGF	HSPG2 LAMC3 NTN4 ATRNL1	6.95e-05	38	109	4	IPR002049
Domain	EGF-like_dom	HSPG2 LAMC3 TECTA PTGS1 PTGS2 HMCN2 ATRNL1 NOTCH1	1.06e-04	249	109	8	IPR000742
Domain	Kringle	HGF F2 MST1	1.24e-04	17	109	3	IPR000001
Domain	Kringle_CS	HGF F2 MST1	1.24e-04	17	109	3	IPR018056
Domain	KRINGLE_2	HGF F2 MST1	1.24e-04	17	109	3	PS50070
Domain	Kringle	HGF F2 MST1	1.24e-04	17	109	3	PF00051
Domain	KRINGLE_1	HGF F2 MST1	1.24e-04	17	109	3	PS00021
Domain	KR	HGF F2 MST1	1.24e-04	17	109	3	SM00130
Domain	EGF_1	HSPG2 LAMC3 PTGS1 PTGS2 NTN4 HMCN2 ATRNL1 NOTCH1	1.25e-04	255	109	8	PS00022
Domain	Ig_I-set	HSPG2 IGFN1 VSIG2 SPEG NCAM2 HMCN2 SIGLEC10	1.25e-04	190	109	7	IPR013098
Domain	I-set	HSPG2 IGFN1 VSIG2 SPEG NCAM2 HMCN2 SIGLEC10	1.25e-04	190	109	7	PF07679
Domain	EGF-like_CS	HSPG2 LAMC3 PTGS1 PTGS2 NTN4 HMCN2 ATRNL1 NOTCH1	1.47e-04	261	109	8	IPR013032
Domain	HATPase_c	HSP90B1 PDK2 MLH3	1.48e-04	18	109	3	SM00387
Domain	HATPase_c	HSP90B1 PDK2 MLH3	1.75e-04	19	109	3	PF02518
Domain	-	RABEPK KLHL30 ATRNL1 KBTBD13	1.75e-04	48	109	4	2.120.10.80
Domain	-	HSP90B1 PDK2 MLH3	2.05e-04	20	109	3	3.30.565.10
Domain	HATPase_C	HSP90B1 PDK2 MLH3	2.38e-04	21	109	3	IPR003594
Domain	Sushi	CSMD2 CSMD3 CFHR4 C2	2.40e-04	52	109	4	PF00084
Domain	CCP	CSMD2 CSMD3 CFHR4 C2	2.77e-04	54	109	4	SM00032
Domain	Kelch-typ_b-propeller	RABEPK KLHL30 ATRNL1 KBTBD13	2.98e-04	55	109	4	IPR015915
Domain	SUSHI	CSMD2 CSMD3 CFHR4 C2	3.19e-04	56	109	4	PS50923
Domain	Kinase-like_dom	SPEG ACAD10 PRKACA PRKACB PRKACG FES IRAK3 PRKG2 PRKX PRKY FOXF1	3.27e-04	542	109	11	IPR011009
Domain	PAN_AP	HGF MST1	3.34e-04	5	109	2	SM00473
Domain	Sushi_SCR_CCP_dom	CSMD2 CSMD3 CFHR4 C2	3.42e-04	57	109	4	IPR000436
Domain	EGF	HSPG2 LAMC3 TECTA PTGS1 PTGS2 ATRNL1 NOTCH1	4.58e-04	235	109	7	SM00181
Domain	CP2	TFCP2 TFCP2L1	4.99e-04	6	109	2	PF04516
Domain	CP2	TFCP2 TFCP2L1	4.99e-04	6	109	2	IPR007604
Domain	PAN	HGF MST1	6.95e-04	7	109	2	PS50948
Domain	Pan_app	HGF MST1	6.95e-04	7	109	2	IPR003609
Domain	PAN_1	HGF MST1	6.95e-04	7	109	2	PF00024
Domain	Kelch_1	RABEPK KLHL30 ATRNL1 KBTBD13	7.48e-04	70	109	4	PF01344
Domain	Kelch_1	RABEPK KLHL30 ATRNL1 KBTBD13	7.48e-04	70	109	4	IPR006652
Domain	Kringle-like	HGF F2 MST1	8.48e-04	32	109	3	IPR013806
Domain	EGF	HSPG2 TECTA PTGS1 PTGS2 NOTCH1	8.61e-04	126	109	5	PF00008
Domain	LAMININ_IVA	HSPG2 LAMC3	9.24e-04	8	109	2	PS51115
Domain	Laminin_B	HSPG2 LAMC3	9.24e-04	8	109	2	PF00052
Domain	LamB	HSPG2 LAMC3	9.24e-04	8	109	2	SM00281
Domain	Laminin_IV	HSPG2 LAMC3	9.24e-04	8	109	2	IPR000034
Domain	EGF_2	HSPG2 LAMC3 PTGS1 PTGS2 HMCN2 ATRNL1 NOTCH1	9.31e-04	265	109	7	PS01186
Domain	Laminin_EGF	HSPG2 LAMC3 NTN4	1.10e-03	35	109	3	PF00053
Domain	Ser/Thr_kinase_AS	SPEG PRKACA PRKACB PRKACG IRAK3 PRKG2 PRKX PRKY	1.17e-03	357	109	8	IPR008271
Domain	PROTEIN_KINASE_ST	SPEG PRKACA PRKACB PRKACG IRAK3 PRKG2 PRKX PRKY	1.28e-03	362	109	8	PS00108
Domain	PROTEIN_KINASE_ATP	SPEG PRKACA PRKACB PRKACG FES IRAK3 PRKG2 PRKX PRKY	1.47e-03	459	109	9	PS00107
Domain	Haem_peroxidase	PTGS1 PTGS2	1.47e-03	10	109	2	IPR010255
Domain	An_peroxidase	PTGS1 PTGS2	1.47e-03	10	109	2	PF03098
Domain	PEROXIDASE_3	PTGS1 PTGS2	1.47e-03	10	109	2	PS50292
Domain	Haem_peroxidase_animal	PTGS1 PTGS2	1.47e-03	10	109	2	IPR019791
Domain	-	PTGS1 PTGS2	1.47e-03	10	109	2	1.10.640.10
Domain	C2-set_2	BTN1A1 SIGLEC10 NECTIN4	1.75e-03	41	109	3	PF08205
Domain	CD80_C2-set	BTN1A1 SIGLEC10 NECTIN4	1.75e-03	41	109	3	IPR013162
Domain	Pkinase	SPEG PRKACA PRKACB PRKACG IRAK3 PRKG2 PRKX PRKY	1.77e-03	381	109	8	PF00069
Domain	Carbonic_anhydrase_a-class_CS	CA3 CA8	2.14e-03	12	109	2	IPR018338
Domain	Growth_fac_rcpt_	HSPG2 LAMC3 NTN4 HMCN2 NOTCH1	2.22e-03	156	109	5	IPR009030
Domain	Prot_kinase_dom	SPEG PRKACA PRKACB PRKACG FES IRAK3 PRKG2 PRKX PRKY	2.26e-03	489	109	9	IPR000719
Domain	PROTEIN_KINASE_DOM	SPEG PRKACA PRKACB PRKACG FES IRAK3 PRKG2 PRKX PRKY	2.39e-03	493	109	9	PS50011
Domain	Kelch_2	RABEPK ATRNL1	2.52e-03	13	109	2	IPR011498
Domain	PMG	KRTAP13-2 KRTAP13-1	2.52e-03	13	109	2	PF05287
Domain	KRTAP_PMG	KRTAP13-2 KRTAP13-1	2.52e-03	13	109	2	IPR007951
Domain	Kelch_2	RABEPK ATRNL1	2.52e-03	13	109	2	PF07646
Domain	EGF_3	HSPG2 PTGS1 PTGS2 HMCN2 ATRNL1 NOTCH1	2.57e-03	235	109	6	PS50026
Domain	CUB	CSMD2 CSMD3 ATRNL1	2.93e-03	49	109	3	PF00431
Domain	CUB	CSMD2 CSMD3 ATRNL1	3.10e-03	50	109	3	SM00042
Domain	Carbonic_anhydrase_a-class	CA3 CA8	3.37e-03	15	109	2	IPR023561
Domain	ALPHA_CA_1	CA3 CA8	3.37e-03	15	109	2	PS00162
Domain	-	CSMD2 CSMD3 ATRNL1	3.47e-03	52	109	3	2.60.120.290
Domain	CUB	CSMD2 CSMD3 ATRNL1	3.66e-03	53	109	3	PS01180
Pathway	KEGG_PRION_DISEASES	NCAM2 PRKACA PRKACB PRKACG PRKX NOTCH1	4.56e-08	35	82	6	M13036
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	PRKACA PRKACB PRKACG PRKX	5.08e-07	12	82	4	M27363
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACB PRKACG	1.88e-06	5	82	3	M26988
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	PRKACA PRKACB PRKACG PRKX	4.80e-06	20	82	4	M759
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACB PRKACG	6.53e-06	7	82	3	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB PRKACG	1.04e-05	8	82	3	M27840
Pathway	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	HS6ST2 EXTL3 HS6ST1 HS6ST3	1.44e-05	26	82	4	M7330
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACA PRKACB PRKACG	1.55e-05	9	82	3	M27877
Pathway	KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.21e-05	10	82	3	M47648
Pathway	REACTOME_HS_GAG_BIOSYNTHESIS	HSPG2 HS6ST2 HS6ST1 HS6ST3	2.97e-05	31	82	4	M685
Pathway	WP_GASTRIC_ACID_PRODUCTION	PGA4 PGA5 PGA3	3.03e-05	11	82	3	M39726
Pathway	WP_CANCER_PATHWAYS	HGF HSP90B1 LAMC3 F2 PTGS2 MST1 BRCA2 PRKACA PRKACB PRKACG FZD10 NOTCH1	3.44e-05	507	82	12	M48302
Pathway	WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN	PRKACA PRKACB PRKACG PRKG2	3.83e-05	33	82	4	M48071
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PRKACA PRKACB PRKACG	4.02e-05	12	82	3	M27950
Pathway	WP_DOPAMINE_METABOLISM	PRKACA PRKACB PRKACG	5.20e-05	13	82	3	M39622
Pathway	REACTOME_CA_DEPENDENT_EVENTS	PRKACA PRKACB PRKACG PRKX	6.07e-05	37	82	4	M749
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	PRKACA PRKACB LPIN2 PRKACG	6.75e-05	38	82	4	M27856
Pathway	KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	8.21e-05	15	82	3	M47794
Pathway	KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	8.21e-05	15	82	3	M47504
Pathway	WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS	HS6ST2 EXTL3 HS6ST1 HS6ST3	9.14e-05	41	82	4	M48095
Pathway	REACTOME_DAG_AND_IP3_SIGNALING	PRKACA PRKACB PRKACG PRKX	9.14e-05	41	82	4	M512
Pathway	KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.01e-04	16	82	3	M47551
Pathway	KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.01e-04	16	82	3	M47645
Pathway	KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.01e-04	16	82	3	M47650
Pathway	REACTOME_RAP1_SIGNALLING	PRKACA PRKACB PRKACG	1.01e-04	16	82	3	M923
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	PRKACA PRKACB PRKACG PRKX	1.10e-04	43	82	4	M29837
Pathway	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	PRKACA PRKACB PRKACG PRKX	1.21e-04	44	82	4	M9011
Pathway	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	PRKACA PRKACB PRKACG	1.22e-04	17	82	3	M26995
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.22e-04	17	82	3	M47544
Pathway	KEGG_APOPTOSIS	PRKACA PRKACB PRKACG IRAK3 PRKX	1.50e-04	87	82	5	M8492
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	PRKACA PRKACB PRKACG	1.72e-04	19	82	3	M27841
Pathway	KEGG_GAP_JUNCTION	PRKACA PRKACB PRKACG PRKG2 PRKX	1.76e-04	90	82	5	M4013
Pathway	KEGG_TASTE_TRANSDUCTION	PRKACA PRKACB PRKACG PRKX	2.33e-04	52	82	4	M5785
Pathway	WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS	CHRNA4 CHRNA5 PRKACA	2.34e-04	21	82	3	M39343
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PRKACA PRKACB PRKACG	2.34e-04	21	82	3	M27485
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	PRKACA PRKACB PRKACG PRKX	2.70e-04	54	82	4	M26911
Pathway	KEGG_VIBRIO_CHOLERAE_INFECTION	PRKACA PRKACB PRKACG PRKX	2.70e-04	54	82	4	M17906
Pathway	KEGG_MELANOGENESIS	PRKACA PRKACB PRKACG FZD10 PRKX	3.01e-04	101	82	5	M7761
Pathway	KEGG_HEDGEHOG_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG PRKX	3.10e-04	56	82	4	M1053
Pathway	BIOCARTA_ACETAMINOPHEN_PATHWAY	PTGS1 PTGS2	3.30e-04	5	82	2	M22024
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	HSPG2 HS6ST2 HS6ST1 HS6ST3	3.32e-04	57	82	4	M692
Pathway	REACTOME_TRIGLYCERIDE_CATABOLISM	PRKACA PRKACB PRKACG	3.52e-04	24	82	3	M10064
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	3.52e-04	24	82	3	M47520
Pathway	REACTOME_DARPP_32_EVENTS	PRKACA PRKACB PRKACG	3.52e-04	24	82	3	M751
Pathway	REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME	PSME4 PRKACA PRKACB PRKACG	4.05e-04	60	82	4	M27470
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	4.48e-04	26	82	3	M47553
Pathway	PID_IL3_PATHWAY	PRKACA PRKACB PRKACG	4.48e-04	26	82	3	M182
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB	4.94e-04	6	82	2	MM14628
Pathway	KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	5.02e-04	27	82	3	M47518
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	5.02e-04	27	82	3	M47519
Pathway	KEGG_OOCYTE_MEIOSIS	PRKACA PRKACB PRKACG PRKX STAG3	5.06e-04	113	82	5	M16817
Pathway	KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	5.60e-04	28	82	3	M47647
Pathway	REACTOME_HS_GAG_BIOSYNTHESIS	HS6ST2 HS6ST1 HS6ST3	6.21e-04	29	82	3	MM14802
Pathway	WP_LIPID_METABOLISM_PATHWAY	PRKACA PRKACB PRKACG	6.21e-04	29	82	3	M39762
Pathway	KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	6.21e-04	29	82	3	M47627
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	PRKACA PRKACB PRKACG	6.21e-04	29	82	3	M39676
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	6.21e-04	29	82	3	M47515
Pathway	REACTOME_SURFACTANT_METABOLISM	PGA4 PGA5 PGA3	6.88e-04	30	82	3	M27566
Pathway	WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS	PRKACA PRKACB PRKACG	6.88e-04	30	82	3	M42578
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB	6.89e-04	7	82	2	MM15560
Pathway	KEGG_LONG_TERM_POTENTIATION	PRKACA PRKACB PRKACG PRKX	7.28e-04	70	82	4	M3115
Pathway	KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	7.58e-04	31	82	3	M47507
Pathway	KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	8.33e-04	32	82	3	M47506
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB PRKACG	9.13e-04	33	82	3	M11575
Pathway	BIOCARTA_ACETAMINOPHEN_PATHWAY	PTGS1 PTGS2	9.15e-04	8	82	2	MM1547
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	CHRNA4 CHRNA5 SLC22A2 PRKACA PRKACB PRKACG PRKX	9.78e-04	270	82	7	M15514
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.09e-03	35	82	3	M47969
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNA5	1.17e-03	9	82	2	M27597
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNA5	1.17e-03	9	82	2	MM15313
Pathway	WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS	PTGS1 PTGS2	1.17e-03	9	82	2	M48307
Pathway	PID_GMCSF_PATHWAY	PRKACA PRKACB PRKACG	1.18e-03	36	82	3	M22
Pathway	REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION	CHRNA4 CHRNA5 PRKACA PRKACB PRKACG PRKX	1.23e-03	205	82	6	M752
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	HSPG2 HS6ST2 HS6ST1 PRKACA PRKACB PRKACG HS6ST3	1.42e-03	288	82	7	M16864
Pathway	REACTOME_MET_ACTIVATES_RAS_SIGNALING	HGF RANBP10	1.46e-03	10	82	2	MM15488
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	PRKACA PRKACB PRKACG PRKX	1.51e-03	85	82	4	M3578
Pathway	REACTOME_RET_SIGNALING	PRKACA PRKACB PRKACG	1.60e-03	40	82	3	M27746
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	PRKACA PRKACB PRKACG	1.72e-03	41	82	3	M39655
Pathway	BIOCARTA_AKAP95_PATHWAY	PRKACB PRKACG	1.78e-03	11	82	2	M5731
Pathway	REACTOME_MET_ACTIVATES_RAS_SIGNALING	HGF RANBP10	1.78e-03	11	82	2	M27740
Pathway	BIOCARTA_PLCE_PATHWAY	PRKACB PRKACG	1.78e-03	11	82	2	M5576
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNA5	1.78e-03	11	82	2	M883
Pathway	BIOCARTA_CFTR_PATHWAY	PRKACB PRKACG	1.78e-03	11	82	2	M12399
Pathway	BIOCARTA_AGPCR_PATHWAY	PRKACB PRKACG	1.78e-03	11	82	2	M19829
Pathway	BIOCARTA_AKAP13_PATHWAY	PRKACB PRKACG	1.78e-03	11	82	2	M17668
Pathway	KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS	EXTL3 HS6ST1	1.78e-03	11	82	2	M47921
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	PRKACA PRKACB PRKACG	1.85e-03	42	82	3	M791
Pathway	KEGG_WNT_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG FZD10 PRKX	1.86e-03	151	82	5	M19428
Pathway	REACTOME_OPIOID_SIGNALLING	PRKACA PRKACB PRKACG PRKX	1.86e-03	90	82	4	M6467
Pathway	KEGG_DILATED_CARDIOMYOPATHY	PRKACA PRKACB PRKACG PRKX	1.86e-03	90	82	4	M835
Pathway	WP_HEDGEHOG_SIGNALING_WP4249	PRKACA PRKACB PRKACG	1.98e-03	43	82	3	M39706
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	PRKACA PRKACB PRKACG	1.98e-03	43	82	3	M933
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	PSME4 PRKACA PRKACB PRKACG	2.10e-03	93	82	4	M27572
Pathway	WP_VASOPRESSINREGULATED_WATER_REABSORPTION	PRKACA PRKACB PRKACG	2.12e-03	44	82	3	M42554
Pathway	BIOCARTA_CARM1_PATHWAY	PRKACB PRKACG	2.12e-03	12	82	2	M7968
Pathway	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNA5	2.12e-03	12	82	2	M48008
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNA5	2.12e-03	12	82	2	MM15312
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	PRKACA PRKACB PRKACG PRKX	2.18e-03	94	82	4	M2843
Pathway	WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION	PTGFRN PTGS1 PTGS2	2.26e-03	45	82	3	M39355
Pathway	REACTOME_GPER1_SIGNALING	PRKACA PRKACB PRKACG	2.26e-03	45	82	3	M45008
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	PRKACA PRKACB PRKACG PRKX	2.27e-03	95	82	4	M29842
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB PRKACG	3.52e-08	3	115	3	2342480
Pubmed	The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	7926498
Pubmed	Crystal structure of human pepsinogen A.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	9561228
Pubmed	The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	21455714
Pubmed	Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	19800305
Pubmed	Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	24170207
Pubmed	Relationships between the human pepsinogen DNA and protein polymorphisms.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3014868
Pubmed	The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2799289
Pubmed	CRYSTALLINE PEPSIN : I. ISOLATION AND TESTS OF PURITY.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	19872561
Pubmed	Human pepsinogen A (PGA): an informative gene complex located at 11q13.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	1968039
Pubmed	The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine.	HS6ST2 HS6ST1 HS6ST3	3.52e-08	3	115	3	10644753
Pubmed	Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8053437
Pubmed	Family and population studies on the human pepsinogen A multigene family.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2566575
Pubmed	Immunoblot technique to visualise serum pepsinogen A isozymogen patterns.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2229438
Pubmed	Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	25314140
Pubmed	Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	19890696
Pubmed	Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8244094
Pubmed	Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	21407214
Pubmed	Isolation of an activation intermediate and determination of the amino acid sequence of the activation segment of human pepsinogen A.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	6774973
Pubmed	Primary structure of human pepsinogen gene.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	6300126
Pubmed	Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	22304859
Pubmed	Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	24004680
Pubmed	Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8038355
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACA PRKACB PRKACG	3.52e-08	3	115	3	19383776
Pubmed	Human pepsinogen A isozymogen patterns in serum and gastric mucosa.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2227273
Pubmed	Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	23034090
Pubmed	A possible association of low pepsinogen I and pepsinogen I/II with low and high body weight in Japanese men.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	24125879
Pubmed	Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8751234
Pubmed	Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3554488
Pubmed	Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	23521833
Pubmed	Close linkage of human chromosomal pepsinogen A genes.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3017318
Pubmed	Serum pepsinogen test for early detection of gastric cancer in a European country.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	21989121
Pubmed	Serum antibodies to H+,K+-ATPase, serum pepsinogen A and Helicobacter pylori in relation to gastric mucosa morphology in patients with low or low-normal concentrations of serum cobalamins.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	9855083
Pubmed	Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first-line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	9797498
Pubmed	The glomerular sieving of pepsinogen A and C in man.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2478370
Pubmed	Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3815274
Pubmed	Pepsinogens: physiology, pharmacology pathophysiology and exercise.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	10675278
Pubmed	Pepsinogen A polymorphism in gastric mucosa and urine, with special reference to patients with gastric cancer.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3780036
Pubmed	Identification of a Glu greater than Lys substitution in the activation segment of human pepsinogen A-3 and -5 isozymogens by peptide mapping using endoproteinase Lys-C.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2901984
Pubmed	Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3839486
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACA PRKACB PRKACG	3.52e-08	3	115	3	12842892
Pubmed	Differential expression of heparan sulfate 6-O-sulfotransferase isoforms in the mouse embryo suggests distinctive roles during organogenesis.	HS6ST2 HS6ST1 HS6ST3	3.52e-08	3	115	3	15499561
Pubmed	Assignment of the pepsinogen gene complex (PGA) to human chromosome region 11q13 by in situ hybridization.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	3467902
Pubmed	The pepsinogens of human gastric mucosa.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	4586732
Pubmed	Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases.	HS6ST2 HS6ST1 HS6ST3	3.52e-08	3	115	3	12611590
Pubmed	Genomic structure and evolution of the human pepsinogen A multigene family.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2892778
Pubmed	The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	24383519
Pubmed	Gene structures of pepsinogens A and C.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	1455184
Pubmed	Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2831884
Pubmed	Localization of pepsinogen (A and C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	2032552
Pubmed	Analysis of the promoter of a human pepsinogen A gene.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	1812762
Pubmed	O6-methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis. The EUROGAST Study Group.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	7923573
Pubmed	Fast detection of phosphorylation of human pepsinogen A, human pepsinogen C and swine pepsinogen using a combination of reversed-phase high-performance liquid chromatography and capillary zone electrophoresis for peptide mapping.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	9061458
Pubmed	Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	12588289
Pubmed	Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	23897256
Pubmed	An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	11566730
Pubmed	The effect of acute and chronic protein loading on urinary pepsinogen A excretion.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	1956484
Pubmed	Transcription regulation of human and porcine pepsinogen A.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8540382
Pubmed	Exploratory findings of audiometry in adult patients with otitis media with high pepsinogen concentrations: a preliminary study.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	22992016
Pubmed	The role of serum pepsinogen in the detection of gastric cancer.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	20981206
Pubmed	Gastric chief cell-specific transcription of the pepsinogen A gene.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	8504820
Pubmed	Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	21970995
Pubmed	Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.	HS6ST2 HS6ST1 HS6ST3	3.52e-08	3	115	3	23223449
Pubmed	Serum pepsinogens in gastric cancer screening.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	20428942
Pubmed	The relationship of Helicobacter pylori colonization, the serum pepsinogen A level, and gastric resection.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	9525001
Pubmed	Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	7886402
Pubmed	Serum pepsinogen and gastric cancer screening.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	17379991
Pubmed	Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.	PGA4 PGA5 PGA3	3.52e-08	3	115	3	21547904
Pubmed	Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation.	HS6ST2 HS6ST1 HS6ST3	3.52e-08	3	115	3	16326709
Pubmed	Stem domains of heparan sulfate 6-O-sulfotransferase are required for Golgi localization, oligomer formation and enzyme activity.	HS6ST2 HS6ST1 HS6ST3	1.41e-07	4	115	3	15226404
Pubmed	Proteoglycans and their roles in brain cancer.	HSPG2 HS6ST2 HS6ST1	1.41e-07	4	115	3	23281850
Pubmed	Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes.	PGA4 PGA5 PGA3	1.41e-07	4	115	3	23047493
Pubmed	Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development.	PGA4 PGA5 PGA3	1.41e-07	4	115	3	11915945
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACA PRKACB PRKACG	1.41e-07	4	115	3	18385332
Pubmed	Analysis of axon guidance defects at the optic chiasm in heparan sulphate sulphotransferase compound mutant mice.	HS6ST2 HS6ST1 HS6ST3	1.41e-07	4	115	3	21951307
Pubmed	Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.	PGA4 PGA5 PGA3	1.41e-07	4	115	3	8322031
Pubmed	Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression.	PGA4 PGA5 PGA3	1.41e-07	4	115	3	17136346
Pubmed	Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.	PGA4 PGA5 PGA3	1.41e-07	4	115	3	12698190
Pubmed	Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.	PRKACA PRKACB PRKACG APOBEC3C	2.61e-07	17	115	4	24189052
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACA PRKACB PRKACG	3.50e-07	5	115	3	21745501
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACA PRKACB PRKACG	3.50e-07	5	115	3	12972513
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACA PRKACB PRKACG	3.50e-07	5	115	3	19483721
Pubmed	Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.	PGA4 PGA5 PGA3	3.50e-07	5	115	3	22066020
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACA PRKACB PRKACG	3.50e-07	5	115	3	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACA PRKACB PRKACG	3.50e-07	5	115	3	19711044
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACA PRKACB PRKACG	6.99e-07	6	115	3	9837753
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACA PRKACB PRKACG	6.99e-07	6	115	3	19197368
Pubmed	Sulfatase 1 is an inhibitor of ductal morphogenesis with sexually dimorphic expression in the urogenital sinus.	HS6ST2 HS6ST1 HS6ST3	1.22e-06	7	115	3	20410206
Pubmed	Dynamic binding of PKA regulatory subunit RI alpha.	PRKACA PRKACB PRKACG	1.22e-06	7	115	3	16407073
Pubmed	Phosphorylation of HIV Nef by cAMP-dependent protein kinase.	PRKACA PRKACB PRKACG	1.22e-06	7	115	3	15629779
Pubmed	CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway.	PRKACA PRKACB PRKACG	1.95e-06	8	115	3	19100722
Pubmed	Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality.	HS6ST2 HS6ST1 HS6ST3	1.95e-06	8	115	3	17405882
Pubmed	Bicc1 links the regulation of cAMP signaling in polycystic kidneys to microRNA-induced gene silencing.	PRKACA PRKX PRKY	1.95e-06	8	115	3	22641646
Pubmed	Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).	PRKACA PRKACB PRKACG	1.95e-06	8	115	3	12628924
Pubmed	Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate.	HS6ST2 HS6ST1 HS6ST3	2.92e-06	9	115	3	21357686
Pubmed	Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.	PRKACA PRKACB PRKACG	2.92e-06	9	115	3	7688126
Pubmed	HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.	PRKACA PRKACB PRKACG	4.16e-06	10	115	3	20433920
Pubmed	Involvement of heparan sulfate 6-O-sulfation in the regulation of energy metabolism and the alteration of thyroid hormone levels in male mice.	HS6ST2 HS6ST1 HS6ST3	5.70e-06	11	115	3	23690091
Pubmed	Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain.	HS6ST2 HS6ST1 HS6ST3	5.70e-06	11	115	3	15944372
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	PRKACA PRKACB PRKACG	7.58e-06	12	115	3	10830164
GeneFamily	Adenosine receptors\|V-set domain containing	VSIG2 PSG4 SIGLEC5 PTGFRN BTN1A1 SIGLEC10 NECTIN4 GPA33	4.12e-07	163	76	8	590
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 IGFN1 VSIG2 SPEG NCAM2 HMCN2	5.94e-05	161	76	6	593
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CSMD3 CFHR4 C2	9.62e-05	57	76	4	1179
GeneFamily	Sulfotransferases, membrane bound	HS6ST2 HS6ST1 HS6ST3	5.00e-04	37	76	3	763
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	BTN1A1 SIGLEC10 NECTIN4	6.31e-04	40	76	3	592
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA4 CHRNA5	2.01e-03	16	76	2	173
GeneFamily	Carbonic anhydrases	CA3 CA8	2.55e-03	18	76	2	460
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_200	TC2N PKHD1 CTSE CA3	1.13e-05	27	111	4	gudmap_developingLowerUrinaryTract_P1_ureter_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000	VSIG2 PTGS1 CLDN11 TC2N KLHL30 EHF PKHD1 NECTIN4 IRAK3 C2 PRKG2 CTSE FOXF1 CA3 CA8	1.22e-05	774	111	15	gudmap_developingLowerUrinaryTract_P1_ureter_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000	PTGS1 KLHL30 IRAK3 C2 CTSE CA3	4.20e-05	121	111	6	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_100	TC2N EHF PKHD1 CTSE CA3	5.91e-05	79	111	5	gudmap_developingLowerUrinaryTract_adult_bladder_100
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_100	PTGS1 TFCP2L1 EHF PKHD1 CTSE	5.91e-05	79	111	5	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#4_top-relative-expression-ranked_100	PKHD1 CTSE CA3	7.41e-05	16	111	3	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_500	PTGS1 C2 CTSE CA3	1.06e-04	47	111	4	gudmap_developingLowerUrinaryTract_P1_ureter_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000	VSIG2 MFSD6 PTGS1 NTN4 TC2N KLHL30 EHF PKHD1 NECTIN4 C2 CTSE FOXF1 CA3	1.20e-04	734	111	13	gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_500	MFSD6 NTN4 TFCP2L1 TC2N EHF PKHD1 NECTIN4 CTSE CA8	1.51e-04	373	111	9	gudmap_developingLowerUrinaryTract_adult_ureter_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500	VSIG2 MFSD6 PTGS1 TC2N KLHL30 EHF PKHD1 CTSE CA3	1.67e-04	378	111	9	gudmap_developingLowerUrinaryTract_adult_bladder_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_100	PCDHA11 CLDN11 FOXF1	1.99e-04	22	111	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500	PTGS1 TC2N EHF PKHD1 NECTIN4 C2 CTSE CA3 CA8	2.11e-04	390	111	9	gudmap_developingLowerUrinaryTract_P1_ureter_500
ToppCell	facs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 TFCP2L1 EHF PKHD1 GPA33 SLC25A48 CA8	5.54e-07	186	115	7	3c4994a1a7db06a61da8170e45e06aaef7896592
ToppCell	(5)_Epithelial_cells-(5)_Glands_duct\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ANKRD66 TFCP2L1 CLDN11 FES IRAK3 C2 CA8	5.54e-07	186	115	7	219b1aeca17503244fabbb780bca58f22c7c0f27
ToppCell	facs-Lung-EPCAM-24m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 TFCP2L1 EHF PKHD1 GPA33 SLC25A48 CA8	5.54e-07	186	115	7	a583d6fc0f1e729f6e9fd18d7b49d6eab9ca32b9
ToppCell	facs-Bladder\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 PTGS1 EHF LPIN2 CTSE GPA33 FOXF1	5.75e-07	187	115	7	dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5
ToppCell	droplet-Bladder\|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 PTGFRN PTGS1 EHF CTSE GPA33 CA3	6.39e-07	190	115	7	170484f7a6f0a0d0792bbe1bb04abad060b7188e
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 CFAP65 NTN4 TFCP2L1 EHF GPA33 CA8	7.61e-07	195	115	7	7ff04c45a02df01e3816f3c1d43585a93182a730
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 CFAP65 NTN4 TFCP2L1 EHF GPA33 CA8	7.61e-07	195	115	7	09605533aa5947bb2e5a6725c1ce89f79d330bf5
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFAP65 NTN4 TC2N BRCA2 CA8	7.17e-06	103	115	5	c11bb0238e81a42dad5d7687c9d22474129d803d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HGF LAMC3 PTGS2 ATRNL1 FZD10 CA8	7.40e-06	180	115	6	280ff5c8f292be1b88120db5ff1788b750644856
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HGF LAMC3 PTGS2 ATRNL1 FZD10 CA8	7.40e-06	180	115	6	fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PTGS1 ATRNL1 EHF LPIN2 CA8	7.40e-06	180	115	6	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A LAMC3 CHRNA4 NTN4 IRAK3 SLC25A48	7.63e-06	181	115	6	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	HS6ST2 TFCP2L1 EHF CTSE CA3 CA8	7.63e-06	181	115	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A LAMC3 NTN4 LPIN2 IRAK3 SLC25A48	8.65e-06	185	115	6	487fa382232564f075960899d50afa0edae5d258
ToppCell	(5)_Glands_duct\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ANKRD66 TFCP2L1 CLDN11 FES C2 CA8	8.92e-06	186	115	6	ad8d5010e5095508f4995e0c6c016a44e8ffb8dd
ToppCell	COVID-19-kidney-Mito-rich_Distal\|kidney / Disease (COVID-19 only), tissue and cell type	HS6ST2 TFCP2L1 EHF PKHD1 FZD10 PRKX	9.19e-06	187	115	6	2ce8038d9d1302e850c1bb536e755598f77ba4b9
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 EHF NECTIN4 CTSE GPA33 NOTCH1	9.19e-06	187	115	6	aa336fb568a24e12c0454265ddd71ed10a6614cf
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A LAMC3 CHRNA4 NTN4 IRAK3 SLC25A48	9.19e-06	187	115	6	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 TFCP2L1 TC2N EHF NECTIN4 CA8	9.48e-06	188	115	6	b1049003ca79c340bb8c78da66bdc0956e1aebc2
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 TFCP2L1 TC2N EHF NECTIN4 CA8	9.48e-06	188	115	6	3dd571bd8e7358b4346dea71f6bf9602dabf583c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTGS1 TFCP2L1 TC2N EHF LPIN2 CA8	1.01e-05	190	115	6	8ff8c586237cf15f930416710bcff45205fe6f70
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VSIG2 TFCP2L1 TC2N EHF LPIN2 CA8	1.04e-05	191	115	6	f98fc372e579ce69409afbbe0f83c03c7ea62632
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VSIG2 TFCP2L1 TC2N EHF LPIN2 CA8	1.04e-05	191	115	6	210589095a3f5d5117174caf6ec110b502f27030
ToppCell	PND14-Epithelial-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTGS1 TFCP2L1 TC2N EHF LPIN2 CA8	1.04e-05	191	115	6	5f8b3b2d38b37027901db9a1cccdbd1ff70f29de
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTGS1 TFCP2L1 TC2N EHF LPIN2 CA8	1.04e-05	191	115	6	2f71f1fb6b5872d84860840b22e789a87ab14eec
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTGS1 TFCP2L1 TC2N EHF LPIN2 CA8	1.04e-05	191	115	6	4ab3056f9af2a6caed39f32288562f480811cd7b
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VSIG2 TFCP2L1 TC2N EHF LPIN2 CA8	1.07e-05	192	115	6	4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	BARD1 EXTL3 DCLRE1B PTGS2 CHRNA5 PTPN9	1.10e-05	193	115	6	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 TC2N EHF NECTIN4 CTSE NOTCH1	1.17e-05	195	115	6	d6e2a5a15bea16de5f7ff09318c67d46ea923203
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCAM2 CSMD3 SHISA7 NTN4 ATRNL1 FZD10	1.20e-05	196	115	6	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NCAM2 CSMD3 SHISA7 NTN4 ATRNL1 FZD10	1.20e-05	196	115	6	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ACAD10 NTN4 PTPRQ PKHD1 SLC25A48 ERVFRD-1	1.27e-05	198	115	6	5a85c286f79cde5811d2595a3397c6fb7685adee
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HS6ST2 HCAR1 EHF CTSE CA3 CA8	1.27e-05	198	115	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HS6ST2 HCAR1 EHF CTSE CA3 CA8	1.27e-05	198	115	6	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 TECTA LPIN2 CTSE CA3	1.31e-05	199	115	6	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 TECTA LPIN2 CTSE CA3	1.31e-05	199	115	6	6c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 TECTA LPIN2 CTSE CA3	1.31e-05	199	115	6	284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 DCLRE1B TECTA LPIN2 CTSE	1.35e-05	200	115	6	f100edfd2b3b742458cbbf34de9c403c4d272d3c
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R\|Neuronal / cells hierarchy compared to all cells using T-Statistic	THSD7A LAMC3 NTN4 CLDN11 IRAK3 SLC25A48	1.35e-05	200	115	6	c1797542541747b524c9c22c723d24c8d027d486
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial\|2m / Sample Type, Dataset, Time_group, and Cell type.	CPA4 HGF IGFN1 LAMC3 PTGS2 AOPEP	1.35e-05	200	115	6	3da9441c0f1e242f0d195de47ecd4c24dfdca232
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	CPA4 HGF IGFN1 LAMC3 PTGS2 AOPEP	1.35e-05	200	115	6	eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 DCLRE1B TECTA LPIN2 CTSE	1.35e-05	200	115	6	f99e214eb680fd82a33f2b1524fbfca265d1cc42
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RANBP10 PGA4 DCLRE1B TECTA LPIN2 CTSE	1.35e-05	200	115	6	d85074b362b11e5a523a5325d203a61aa2759a7a
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST\|Neuronal / cells hierarchy compared to all cells using T-Statistic	THSD7A LAMC3 NTN4 CLDN11 IRAK3 SLC25A48	1.35e-05	200	115	6	53d5e427f0cbf5cf0b63efe4ec01da302f555704
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	THSD7A LAMC3 NTN4 CLDN11 IRAK3 SLC25A48	1.35e-05	200	115	6	a0cc84add181109bb66ba9d49c732e1790222c96
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TFCP2L1 HMCN2 HS6ST3 GPA33 ERVFRD-1	2.06e-05	128	115	5	082b3dc312b033c9b21cf73499009a1dc049ee2b
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-\|Striatum / BrainAtlas - Mouse McCarroll V32	ANKRD66 VSIG2 LAMC3 ACAD10 HS6ST3	2.57e-05	134	115	5	a3547a68012d879d4dfe80394eace70808722e43
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)\|Striatum / BrainAtlas - Mouse McCarroll V32	ANKRD66 VSIG2 LAMC3 ACAD10 HS6ST3	2.57e-05	134	115	5	9458e2d0dbc18d9025b66b59f3ecc2fbc5384940
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A HCAR1 HS6ST1 HS6ST3 CA8	3.17e-05	140	115	5	e64f6aa57bc069cfe970089bd1c298433bfaf771
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IGFN1 SPEG KLHL30 ATRNL1 STAG3	3.62e-05	144	115	5	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TECTA CSMD3 PTPRQ PKHD1 CES4A	3.74e-05	145	115	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Bronchial_Biopsy-Epithelial-Goblet_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CPA4 VSIG2 HCAR1 NTN4 C2	3.87e-05	146	115	5	a4f2e3ea79e7154873c01739672ec6454547e6a6
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PTGS1 HS6ST1 IRAK3 PRKG2 ERVFRD-1	4.69e-05	152	115	5	32634195048858ae84605c61e43c542d90f7cab5
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PTGS1 HS6ST1 IRAK3 PRKG2 ERVFRD-1	4.69e-05	152	115	5	0eb185b2404f015efff1bd140e0c502d714720fb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CSMD3 NTN4 TFCP2L1 KLHL30 CA8	4.69e-05	152	115	5	655d47efe0608d729801f1f01668e84c1bc0675f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RANBP10 SIGLEC5 LAMC3 SIGLEC10 PGA3	4.84e-05	153	115	5	ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RANBP10 SIGLEC5 LAMC3 SIGLEC10 PGA3	4.84e-05	153	115	5	a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RANBP10 SIGLEC5 LAMC3 SIGLEC10 PGA3	4.84e-05	153	115	5	90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	IGFN1 KLHL30 ATRNL1 PTPRQ STAG3	5.15e-05	155	115	5	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A TECTA CSMD3 CHRNA5 KRTAP13-1	5.15e-05	155	115	5	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	CPA4 SPEG MST1 ATRNL1 PTPRQ	5.30e-05	156	115	5	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HGF THSD7A VSIG2 PTGFRN HS6ST3	5.47e-05	157	115	5	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	PBMC-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	VSIG2 PTGFRN PHF2 TFCP2L1	5.79e-05	81	115	4	6d1e524f000b71c935359afc801a1d31f218fec8
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A BARD1 TECTA CSMD3 CHRNA5	6.16e-05	161	115	5	3b5d7a3dab479c6959a428f3954dedd989900276
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTN4 PTPRQ PKHD1 SLC25A48 ERVFRD-1	6.16e-05	161	115	5	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TECTA CSMD3 PTPRQ PKHD1 CES4A	6.34e-05	162	115	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPA4 PTGS1 MST1 ATRNL1 PTPRQ	6.72e-05	164	115	5	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	Mild-Myeloid-Mast\|Mild / Condition, Lineage, Cell class and cell subclass	HSPG2 THSD7A PTGS1 HS6ST1 PRKG2	6.92e-05	165	115	5	5fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCell	Mild-Myeloid-Mast-\|Mild / Condition, Lineage, Cell class and cell subclass	HSPG2 THSD7A PTGS1 HS6ST1 PRKG2	6.92e-05	165	115	5	93d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A BARD1 CSMD3 PTGS1 CHRNA5	7.53e-05	168	115	5	f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCell	Control-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	HS6ST2 FES IRAK3 SCART1 ERVFRD-1	7.53e-05	168	115	5	d7118d39253ed9790908b850088ebfc5a86f4065
ToppCell	P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VSIG2 TFCP2L1 TC2N EHF CA8	7.97e-05	170	115	5	6c0619cbe2f01a6de18da0a137f92bda0cbdf075
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VSIG2 TFCP2L1 TC2N EHF CA8	7.97e-05	170	115	5	d0ed3a8a7ad96c05641ec409b0a69c4fb094893c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 CFAP65 TC2N EHF CA8	7.97e-05	170	115	5	2c5a1469e5743870e96e6c2cc92f0c5096b79f51
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 CFAP65 TC2N EHF CA8	7.97e-05	170	115	5	9bea81031cdfe45e8cddac3a3afd9ca6c331c45a
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 HCAR1 LAMC3 SLC22A2 C2	8.89e-05	174	115	5	2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 HCAR1 LAMC3 SLC22A2 C2	8.89e-05	174	115	5	eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 PKHD1 CTSE GPA33 CA3	9.13e-05	175	115	5	8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7
ToppCell	P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VSIG2 TFCP2L1 TC2N EHF CA8	9.13e-05	175	115	5	8a4ed775ff973123dbcfe9c809959d11a62450c9
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 PKHD1 CTSE GPA33 CA3	9.13e-05	175	115	5	c083abe368e5c0dc2b0f27f375c9271a2d7ff64f
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 HCAR1 LAMC3 SLC22A2 C2	9.63e-05	177	115	5	599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCell	Control-Lymphoid-ILC_B\|Control / Disease state, Lineage and Cell class	HS6ST2 SCART1 LPAL2 PRKX PRKY	9.63e-05	177	115	5	3d0f4b4054185ba77071efbe53df34fee84b9b24
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEG NCAM2 PTGS1 ADGRG4 FOXF1	9.89e-05	178	115	5	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEG NCAM2 PTGS1 ADGRG4 FOXF1	9.89e-05	178	115	5	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	HCAR1 EHF NECTIN4 CA3 CA8	9.89e-05	178	115	5	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKLE2 TFCP2L1 TC2N EHF NECTIN4	1.02e-04	179	115	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 ADGRG4 PRKG2 CTSE GPA33	1.04e-04	180	115	5	d1beaf1f106c7efaeaf61f29742d0a7310a83916
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 ADGRG4 PRKG2 CTSE GPA33	1.04e-04	180	115	5	156b988b71f6dcf3117c1e5f4625632cb97e54f2
ToppCell	droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 SHISA7 TFCP2L1 EHF CA8	1.10e-04	182	115	5	c1e0be27064e14043b78ae501b02d4e9542267a3
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A TFCP2L1 SLC22A2 PKHD1 SLC25A48	1.10e-04	182	115	5	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 SHISA7 TFCP2L1 EHF CA8	1.10e-04	182	115	5	3c9b4869d357884ae4bcd22a9872faf83a5cfc6d
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	VSIG2 TFCP2L1 TC2N EHF CA8	1.13e-04	183	115	5	23e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	VSIG2 TFCP2L1 TC2N EHF CA8	1.13e-04	183	115	5	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	PND07-28-samps-Epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	VSIG2 TFCP2L1 TC2N EHF CA8	1.13e-04	183	115	5	a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A LAMC3 NTN4 IRAK3 SLC25A48	1.13e-04	183	115	5	6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A CHRNA4 NTN4 IRAK3 SLC25A48	1.13e-04	183	115	5	e3ffef2b57dc5b96466dccc9cd54ba326ccf378a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A LAMC3 NTN4 IRAK3 SLC25A48	1.13e-04	183	115	5	5e361be3ae3fe05098968e58427630127bd12675
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 NCAM2 CSMD3 PTPRQ PKHD1	1.16e-04	184	115	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIG2 CFAP65 NTN4 TFCP2L1 EHF	1.16e-04	184	115	5	886d2d9bf2fe31207f17e3edc309ef44029924e1
ToppCell	wk_20-22-Mesenchymal-Mesothelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CPA4 PTGS1 MST1 PTPRQ CTSE	1.16e-04	184	115	5	804f8a41cd6b1361448872bf352bf0a38a0fac66
Drug	AC1LAIK6	PTGS1 PTGS2 PRKACA PRKACB PRKACG CA3 CA8	7.64e-07	101	114	7	CID000469113
Drug	LY83583	PTGS1 PTGS2 PRKACA PRKACB PRKACG C2 PRKG2	9.95e-07	105	114	7	CID000003976
Drug	tryptanthrin	HGF PTGS1 PTGS2 C2	1.04e-06	16	114	4	CID000073549
Drug	proglumetacin	PGA5 PTGS1 PTGS2	2.42e-06	6	114	3	CID000004921
Drug	KBT-3022	F2 PTGS1 PTGS2	2.42e-06	6	114	3	CID000065870
Drug	oxindanac	PGA5 PTGS1 PTGS2	2.42e-06	6	114	3	CID000068879
Drug	S35b	F2 PTGS1 PTGS2	2.42e-06	6	114	3	CID000193841
Drug	AH6809	PTGS1 PTGS2 PRKACA PRKACB PRKACG	3.00e-06	45	114	5	CID000119461
Drug	Rp-8-Br-cGMPS	PTGS1 PRKACA PRKACB PRKACG PRKG2	3.35e-06	46	114	5	CID003035839
Drug	Sp-8-Cl-cAMPS	PRKACA PRKACB PRKACG PRKG2	4.07e-06	22	114	4	CID000133987
Drug	satigrel	F2 PTGS1 PTGS2	4.22e-06	7	114	3	CID000065913
Drug	LMWH	HGF HSPG2 HS6ST2 LAMC3 EXTL3 F2 PGA5 CHRNA4 CFHR4 HS6ST1 PRKACA PRKACB PRKACG HS6ST3	5.88e-06	663	114	14	CID000000772
Drug	H-9 dihydrochloride	LAMC3 PTGS1 PRKACA PRKACB PRKACG PRKG2	6.10e-06	90	114	6	CID000003544
Drug	Thromboxane B2	F2 PTGS1 PTGS2	6.72e-06	8	114	3	ctd:D013929
Drug	AC1OCF9M	HSPG2 EXTL3 PTGS1 PTGS2	1.29e-05	29	114	4	CID006918304
Drug	phenylpropionic acid	CPA4 ACAD10 PTGS1 PTGS2 C2 CA3 CA8	2.14e-05	167	114	7	CID000000107
Drug	8-pCPT-cGMP	F2 PRKACA PRKACB PRKACG PRKG2	2.17e-05	67	114	5	CID000123969
Drug	N6-monobutyryl-cAMP	BTN1A1 PRKACA PRKACB PRKACG	2.18e-05	33	114	4	CID000115029
Drug	Tolmetin	PTGS1 PTGS2	2.49e-05	2	114	2	DB00500
Drug	Piroxicam	PTGS1 PTGS2	2.49e-05	2	114	2	DB00554
Drug	Fenoprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00573
Drug	Tenoxicam	PTGS1 PTGS2	2.49e-05	2	114	2	DB00469
Drug	Ketorolac	PTGS1 PTGS2	2.49e-05	2	114	2	DB00465
Drug	Nabumetone	PTGS1 PTGS2	2.49e-05	2	114	2	DB00461
Drug	AC1O5RN5	PTGS1 PTGS2	2.49e-05	2	114	2	CID006439421
Drug	Tiaprofenic acid	PTGS1 PTGS2	2.49e-05	2	114	2	DB01600
Drug	Acetaminophen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00316
Drug	Antrafenine	PTGS1 PTGS2	2.49e-05	2	114	2	DB01419
Drug	Trisalicylate-choline	PTGS1 PTGS2	2.49e-05	2	114	2	DB01401
Drug	Antipyrine	PTGS1 PTGS2	2.49e-05	2	114	2	DB01435
Drug	gamma-Homolinolenic acid	PTGS1 PTGS2	2.49e-05	2	114	2	DB00154
Drug	Salsalate	PTGS1 PTGS2	2.49e-05	2	114	2	DB01399
Drug	Salicylate-sodium	PTGS1 PTGS2	2.49e-05	2	114	2	DB01398
Drug	Magnesium salicylate	PTGS1 PTGS2	2.49e-05	2	114	2	DB01397
Drug	Bismuth Subsalicylate	PTGS1 PTGS2	2.49e-05	2	114	2	DB01294
Drug	Lumiracoxib	PTGS1 PTGS2	2.49e-05	2	114	2	DB01283
Drug	2-methoxybenzoic acid	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:C081914
Drug	Oxaprozin	PTGS1 PTGS2	2.49e-05	2	114	2	DB00991
Drug	Bromfenac	PTGS1 PTGS2	2.49e-05	2	114	2	DB00963
Drug	Suprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00870
Drug	Diflunisal	PTGS1 PTGS2	2.49e-05	2	114	2	DB00861
Drug	Carprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00821
Drug	Meloxicam	PTGS1 PTGS2	2.49e-05	2	114	2	DB00814
Drug	Naproxen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00788
Drug	Mefenamic acid	PTGS1 PTGS2	2.49e-05	2	114	2	DB00784
Drug	Flurbiprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB00712
Drug	MDL 035	PTGS1 PTGS2	2.49e-05	2	114	2	CID000053454
Drug	tricin	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:C017769
Drug	Lornoxicam	PTGS1 PTGS2	2.49e-05	2	114	2	DB06725
Drug	N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:C468797
Drug	Ibuprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB01050
Drug	Ketoprofen	PTGS1 PTGS2	2.49e-05	2	114	2	DB01009
Drug	SC 299	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:C409370
Drug	flosulide	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:C059178
Drug	cimicoxib	PTGS1 PTGS2	2.49e-05	2	114	2	CID000213053
Drug	Maleimides	PTGS1 PTGS2	2.49e-05	2	114	2	ctd:D008301
Drug	Nepafenac	PTGS1 PTGS2	2.49e-05	2	114	2	DB06802
Drug	cicaprost	PTGS1 PTGS2 PRKACA PRKACB PRKACG	2.69e-05	70	114	5	CID005311044
Drug	sulprostone	PTGS1 PTGS2 PRKACA PRKACB PRKACG	2.88e-05	71	114	5	CID005312153
Drug	1-(5-isoquinolinesulfonyl)-2-methylpiperazine	HGF LAMC3 F2 PTGS1 PTGS2 PRKACA PRKACB PRKACG PRKG2	2.94e-05	314	114	9	CID000003542
Drug	8-N3cAMP	PRKACA PRKACB PRKACG	4.27e-05	14	114	3	CID006426627
Drug	8-(6-aminohexyl)amino cyclic AMP	PRKACA PRKACB PRKACG	4.27e-05	14	114	3	CID000161999
Drug	butaprost	PTGS1 PTGS2 PRKACA PRKACB PRKACG	4.55e-05	78	114	5	CID005311035
Drug	sodium nitroprusside	F2 PTGS1 PTGS2 PRKACA PRKACB PRKACG C2 PRKG2	5.17e-05	261	114	8	CID000045469
Drug	MK-447	F2 PTGS1 PTGS2	5.32e-05	15	114	3	CID000119286
Drug	NA-382	PRKACA PRKACB PRKACG	5.32e-05	15	114	3	CID000132534
Drug	Pyrilamine maleate [59-33-6]; Up 200; 10uM; PC3; HT_HG-U133A	PTCRA LAMC3 ACAD10 PTGS2 PRICKLE3 PRKX STAG3	5.58e-05	194	114	7	5869_UP
Drug	iloprost	F2 PTGS1 PTGS2 PRKACA PRKACB PRKACG	5.89e-05	134	114	6	CID005311181
Drug	SQ22536	PTGS1 PTGS2 PRKACA PRKACB PRKACG PRKG2	6.14e-05	135	114	6	CID000005270
Drug	Pyrazines	PTGS1 PTGS2 CHRNA4	6.53e-05	16	114	3	ctd:D011719
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	PDK2 SPEG EXTL3 PTGS1 PRKACA APOBEC3C PRKG2	6.55e-05	199	114	7	1509_UP
Drug	firocoxib	PTGS1 PTGS2	7.43e-05	3	114	2	CID000208910
Drug	itazigrel	PTGS1 PTGS2	7.43e-05	3	114	2	CID000051087
Drug	nesodine	PTGS1 PTGS2	7.43e-05	3	114	2	CID006475455
Drug	Meclofenamic acid	PTGS1 PTGS2	7.43e-05	3	114	2	DB00939
Drug	Acetylsalicylic acid	PTGS1 PTGS2	7.43e-05	3	114	2	DB00945
Drug	Salicyclic acid	PTGS1 PTGS2	7.43e-05	3	114	2	DB00936
Drug	Phenylbutazone	PTGS1 PTGS2	7.43e-05	3	114	2	DB00812
Drug	Etodolac	PTGS1 PTGS2	7.43e-05	3	114	2	DB00749
Drug	1a, 1b-dihomo-PGF2	PTGS1 PTGS2	7.43e-05	3	114	2	CID006443812
Drug	malabaricone C	PTGS1 PTGS2	7.43e-05	3	114	2	ctd:C071787
Drug	malabaricone B	PTGS1 PTGS2	7.43e-05	3	114	2	ctd:C071788
Drug	2-propionyloxybenzoic acid	PTGS1 PTGS2	7.43e-05	3	114	2	CID000095938
Drug	17-hydroxy-ent-kaur-15-en-19-oic acid	PTGS1 PTGS2	7.43e-05	3	114	2	CID000169654
Drug	AHR-10037	PTGS1 PTGS2	7.43e-05	3	114	2	CID000132843
Drug	Mannans	PTGS2 IRAK3	7.43e-05	3	114	2	ctd:D008351
Drug	zaprinast	PTGS1 PTGS2 PRKACA PRKACB PRKACG PRKG2	7.81e-05	141	114	6	CID000005722
Drug	lonazolac	PGA5 PTGS1 PTGS2	7.90e-05	17	114	3	CID000068706
Drug	4,4'-diisothiocyanostilbene-2,2'-disulfonic acid	F2 PRKACA PRKACB PRKACG C2 PRKG2 CA3	8.14e-05	206	114	7	CID000040600
Drug	8-azido cyclic AMP	PRKACA PRKACB PRKACG	9.44e-05	18	114	3	CID000115296
Drug	Starlicide	F2 PRKACA PRKACB PRKACG	1.06e-04	49	114	4	CID000007255
Drug	valdecoxib	EXTL3 PTGS1 PTGS2 CA3	1.06e-04	49	114	4	CID000119607
Drug	8-azidoadenosine	PRKACA PRKACB PRKACG	1.12e-04	19	114	3	CID000160751
Drug	8-thiomethyl-cAMP	PRKACA PRKACB PRKACG	1.12e-04	19	114	3	CID000093140
Drug	CGS 13080	F2 PTGS1 PTGS2	1.12e-04	19	114	3	CID000055390
Drug	WEB 2170	HGF F2 PTGS1 PTGS2	1.15e-04	50	114	4	CID000065923
Drug	triethylamine	PRKACA PRKACB PRKACG PRKG2	1.15e-04	50	114	4	CID000008471
Drug	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	HGF F2 PTGS1 PTGS2 CHRNA4	1.23e-04	96	114	5	ctd:C080955
Drug	Tacrine	HGF PTGS2 CHRNA4 SLC22A2	1.44e-04	53	114	4	ctd:D013619
Drug	Fc 6	TFCP2 C2	1.48e-04	4	114	2	CID011963939
Disease	gliosarcoma (biomarker_via_orthology)	PTGS1 PTGS2	1.35e-05	2	109	2	DOID:3071 (biomarker_via_orthology)
Disease	glioblastoma (biomarker_via_orthology)	PTGS1 PTGS2	8.07e-05	4	109	2	DOID:3068 (biomarker_via_orthology)
Disease	Intrahepatic Cholangiocarcinoma	PTGS2 PRKACA PRKACB	9.38e-05	24	109	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	PTGS2 PRKACA PRKACB	9.38e-05	24	109	3	C3805278
Disease	calcium measurement	CPA4 HGF MFSD6 ZMYM2 TC2N PRICKLE3 AOPEP SLC22A2 EHF L3MBTL3	1.14e-04	628	109	10	EFO_0004838
Disease	Cholangiocarcinoma	PTGS2 PRKACA PRKACB	1.20e-04	26	109	3	C0206698
Disease	Intestinal Polyps	PTGS1 PTGS2	1.34e-04	5	109	2	C0021846
Disease	1,5 anhydroglucitol measurement	PCDHA11 NCAM2 PCDHA5	1.67e-04	29	109	3	EFO_0008009
Disease	nicotine dependence (is_implicated_in)	CHRNA4 CHRNA5	2.01e-04	6	109	2	DOID:0050742 (is_implicated_in)
Disease	ulcerative colitis (implicated_via_orthology)	PTGS1 PTGS2	2.81e-04	7	109	2	DOID:8577 (implicated_via_orthology)
Disease	adenocarcinoma (implicated_via_orthology)	PTGS2 NOTCH1	2.81e-04	7	109	2	DOID:299 (implicated_via_orthology)
Disease	lipoprotein A measurement, apolipoprotein A 1 measurement	SLC22A2 LPAL2	2.81e-04	7	109	2	EFO_0004614, EFO_0006925
Disease	Reperfusion Injury	HGF PTGS1 PTGS2 IRAK3	3.38e-04	89	109	4	C0035126
Disease	parental longevity	NCAM2 DCLRE1B CHRNA4 CHRNA5 SLC22A2 FES LPAL2 HS6ST3	5.06e-04	494	109	8	EFO_0007796
Disease	Creutzfeldt-Jakob disease (is_marker_for)	PTGS1 PTGS2	5.97e-04	10	109	2	DOID:11949 (is_marker_for)
Disease	Asthma, Occupational	PTGS1 PTGS2	5.97e-04	10	109	2	C0264423
Disease	esophagus squamous cell carcinoma (is_implicated_in)	CHRNA5 BRCA2 FES	6.21e-04	45	109	3	DOID:3748 (is_implicated_in)
Disease	Thrombus	HGF F2 PTGS2	6.63e-04	46	109	3	C0087086
Disease	cryptic phenotype measurement	CHRNA4 CHRNA5 FES	7.06e-04	47	109	3	EFO_0021487
Disease	Adrenal Gland Neoplasms	PTGS2 PRKACA	7.28e-04	11	109	2	C0001624
Disease	Adrenal Cancer	PTGS2 PRKACA	7.28e-04	11	109	2	C0750887
Disease	Thrombosis	HGF F2 PTGS2	7.98e-04	49	109	3	C0040053
Disease	alcohol use disorder (implicated_via_orthology)	CHRNA4 PRKACA PRKACB PRKACG NOTCH1	8.02e-04	195	109	5	DOID:1574 (implicated_via_orthology)
Disease	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	CHRNA4 CHRNA5	8.71e-04	12	109	2	C1861063
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	HGF TECTA PTPRQ	8.98e-04	51	109	3	cv:CN043650
Disease	nervous system disorder	PTGS2 CHRNA4 NOTCH1	1.00e-03	53	109	3	C0027765
Disease	systemic scleroderma (is_marker_for)	HGF F2 PTGS2	1.00e-03	53	109	3	DOID:418 (is_marker_for)
Disease	hyperglycemia (is_marker_for)	HSPG2 F2	1.03e-03	13	109	2	DOID:4195 (is_marker_for)
Disease	Connective Tissue Diseases	SLC39A13 NOTCH1	1.03e-03	13	109	2	C0009782
Disease	renal cell carcinoma (biomarker_via_orthology)	PTGS1 PTGS2	1.20e-03	14	109	2	DOID:4450 (biomarker_via_orthology)
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BARD1 BRCA2	1.20e-03	14	109	2	C0677776
Disease	Barrett Epithelium	HGF PTGS2	1.57e-03	16	109	2	C1258085
Disease	Barrett Esophagus	HGF PTGS2	1.57e-03	16	109	2	C0004763
Disease	cholangiocarcinoma (is_marker_for)	HGF PTGS2 NOTCH1	1.73e-03	64	109	3	DOID:4947 (is_marker_for)
Disease	Gastric ulcer	PTGS1 PTGS2	1.99e-03	18	109	2	C0038358
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	RANBP10 HCAR1 SLC22A2 LPAL2 L3MBTL3	2.12e-03	243	109	5	EFO_0004612, EFO_0020944
Disease	Cardiomyopathies, Primary	HGF PDK2 PTGS2	2.15e-03	69	109	3	C0033141
Disease	Myocardial Diseases, Secondary	HGF PDK2 PTGS2	2.15e-03	69	109	3	C0036529
Disease	bipolar disorder (is_marker_for)	PTGS1 PTGS2	2.22e-03	19	109	2	DOID:3312 (is_marker_for)
Disease	carotid artery disease (is_marker_for)	HGF HSPG2	2.22e-03	19	109	2	DOID:3407 (is_marker_for)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	BARD1 MLH3	2.22e-03	19	109	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	BARD1 MLH3	2.22e-03	19	109	2	C2936783
Disease	body surface area	ACAD10 ATP13A2 SLC39A13 AOPEP PKHD1 PRKG2 HS6ST3 L3MBTL3	2.69e-03	643	109	8	EFO_0022196
Disease	BREAST CANCER	BARD1 BRCA2	2.71e-03	21	109	2	114480
Disease	non-small cell lung carcinoma	CHRNA5 BRCA2 LINC00114	2.73e-03	75	109	3	EFO_0003060
Disease	Nonsyndromic genetic hearing loss	HGF TECTA PTPRQ	2.83e-03	76	109	3	cv:C5680182
Disease	Esophageal Neoplasms	PTGS1 PTGS2 MLH3	3.05e-03	78	109	3	C0014859
Disease	nicotine dependence	CHRNA4 CHRNA5 SLC25A48	3.05e-03	78	109	3	EFO_0003768
Disease	Malignant neoplasm of esophagus	PTGS1 PTGS2 MLH3	3.05e-03	78	109	3	C0546837
Disease	Mammary Carcinoma, Human	BARD1 PTGS1 PTGS2 MST1 BRCA2 L3MBTL3 NOTCH1	3.40e-03	525	109	7	C4704874
Disease	Mammary Neoplasms, Human	BARD1 PTGS1 PTGS2 MST1 BRCA2 L3MBTL3 NOTCH1	3.40e-03	525	109	7	C1257931
Disease	Mammary Neoplasms	BARD1 PTGS1 PTGS2 MST1 BRCA2 L3MBTL3 NOTCH1	3.47e-03	527	109	7	C1458155

Protein segments in the cluster

Peptide	Gene	Start	Entry
DPSLQPWSVSYDGGS	CA3	41	P07451
QPGCSYPTSWLSSQE	LINC00114	6	Q6XXX2
WTPPAIYKSSCSIDV	CHRNA4	151	P43681
AVLCYSPSDRQSWPS	ANKLE2	861	Q86XL3
TGCPVCYTPAWIQDL	BARD1	81	Q99728
PYSSSQDCVWLITVP	CSMD2	2201	Q7Z408
GFPGNYPSSLDCTWT	CSMD3	2126	Q7Z407
CLECTSVGWYPEPQV	BTN1A1	161	Q13410
YGTLSPTTPFCWIKD	ADGRG4	2876	Q8IZF6
YTSWSPCPDCAGEVA	APOBEC3C	91	Q9NRW3
YGARPCLVTSVGWTP	ANKRD66	66	B4E2M5
SQWCPTGSRSYSSVP	ACAD10	626	Q6JQN1
SVTWTSDQSGRPCVY	AOPEP	256	Q8N6M6
SSTWARPLYCSPITA	DCLRE1B	41	Q9H816
DAFSLLAYSDPWSCP	RANBP10	541	Q6VN20
KAWIYCESLSGPAPS	TP53I13	141	Q8NBR0
CIASGYPTPDISWSK	HSPG2	3596	P98160
ATWYTLTVPGDSPCA	RABEPK	16	Q7Z6M1
IGWASYAPDPTGATC	RRH	161	O14718
YAPDPTGATCTINWR	RRH	166	O14718
LSWPDYGVPSSAASL	PTPN9	466	P43378
CYNPVTDAWSVIASP	KLHL30	441	Q0D2K2
AYWTSPPGCPTVFSE	L3MBTL3	86	Q96JM7
GSSNLWVPSVYCSSL	PGA5	96	P0DJD9
PTLVCSRAVGSWSYS	PCDHA11	736	Q9Y5I1
YGPSPATDGTWTNLA	PTCRA	76	Q6ISU1
TWTLCGTPEYLAPEI	PRKACA	196	P17612
PSGWTGLYCDVPSVS	NOTCH1	1086	P46531
TCQSKEGSPTPQYSW	GPA33	161	Q99795
SCETDALPEPTVTWY	HMCN2	3061	Q8NDA2
LYFKPTWVGCSSTSP	CFAP65	886	Q6ZU64
YPSPASRLCKSSGQW	C2	56	P06681
VSTSSACVWQLAYPP	LBHD1	51	Q9BQE6
DTGSSNLWVPSVYCT	CTSE	96	P14091
TDCILSDTSPSFPWY	MLH3	706	Q9UHC1
RYSWSGEPLFLTCPT	PDCD2L	266	Q9BRP1
ATTYPPGCLQESWGQ	CES4A	81	Q5XG92
CSPAYWKPSTFGGEV	PTGS2	526	P35354
WDYCPISRCEGDTTP	HGF	461	P14210
SSSCEESWFPKYIVP	IRAK3	536	Q9Y616
PTLLCSSAVGSWSYS	PCDHA5	736	Q9Y5H7
TGYSGPNCTIPGLWT	PTGS1	61	P23219
WAACISYLSAAVPPE	MFSD6	551	Q6ZSS7
LPPCYEGTDWSGCTL	HS6ST1	221	O60243
LPTCYPGDDWSGVSL	HS6ST3	281	Q8IZP7
KTWTFCGTPEYVAPE	PRKG2	606	Q13237
WTAVYLPASSPCTLG	MTMR4	566	Q9NYA4
WCVPSTEPKNTSTYR	PDK2	391	Q15119
GSSNLWVPSVYCSSL	PGA3	96	P0DJD8
WSEPAVITGPTCYLI	PTPRQ	1601	Q9UMZ3
GDGTRDPCLPYSWIS	POP1	401	Q99575
SGCASEEYAWVPPGL	PRICKLE3	86	O43900
TESPCALVASQYGWS	HSP90B1	641	P14625
RSYGDLSPPCSNWVE	BTBD18	621	B2RXH4
SCAPLCTPGVDVYWS	FZD10	206	Q9ULW2
GTVTWTPPANYKSSC	CHRNA5	156	P30532
SVSSVRLSGYCGSPW	ATP13A2	31	Q9NQ11
TWTLCGTPEYLAPEI	PRKACB	196	P22694
TWTLCGTPEYLAPEI	PRKACG	196	P22612
WSTPTKDCTSGPYTA	BRCA2	3191	P51587
PPAWTDSYSTCNVSS	EHF	21	Q9NZC4
TVTDFYRSWNCAPGP	EXTL3	596	O43909
CTTVYPASGSSIDWA	CPA4	356	Q9UI42
WVYEGSLTIPPCSEG	CA8	216	P35219
STNDWVVTCGYTIPT	CLDN11	26	O75508
PYGQCLEWQTATCSP	ATRNL1	926	Q5VV63
YVTCSNGDWSEPPRC	CFHR4	251	Q92496
SNYVTCSNGEWSEPP	CFHR4	496	Q92496
PTSEELPSCYTGDDW	HS6ST2	356	Q96MM7
LYFLWTVPSSACDPS	HCAR1	241	Q9BXC0
WEPTSCQTSYVESSP	KRTAP13-1	61	Q8IUC0
WEPTSCQTSYVESSP	KRTAP13-2	61	Q52LG2
WLPCHVGTVPVTTYT	IGFN1	891	Q86VF2
GPWCYTTDPAVRFQS	MST1	166	P26927
ILTCDPATPAASYQW	PSG4	166	Q00888
PCRDGWVYETPGSSI	SLC22A2	121	O15244
LPEAWAYTCSASPGG	SLC39A13	126	Q96H72
YFSIISPKEWGTSCP	C1orf50	131	Q9BV19
GSSNLWVPSVYCSSL	PGA4	96	P0DJD7
CWAYEPGQRPSFSTI	FES	796	P07332
YYCSVTPWVKSPTGS	PTGFRN	791	Q9P2B2
AVYSGSAAAWPPSAS	FOXF1	261	Q12946
TFYECPSTAPWEPVG	RTL1	606	A6NKG5
ECTISASSPLYPAFW	RNF135	401	Q8IUD6
YGDPTLCPTWATDAL	QTRT1	381	Q9BXR0
PSGWIYATLTPVDCL	PHF2	316	O75151
DCIVTPYSDWTSCPS	THSD7A	771	Q9UPZ6
QCRDLSWPSSYGDTP	TC2N	246	Q8N9U0
DCSAGPWCYTTDPNV	LPAL2	81	Q16609
LYPESWTDRGCTCPI	NTN4	566	Q9HB63
TWTLCGTPEYLAPEV	PRKY	201	O43930
VYSLPQLLGPSCSWE	SIGLEC5	331	O15389
ASCSNYDTPRWATTP	SHISA7	126	A6NL88
GSPPVYSVTSWLAGC	PKHD1	736	P08F94
YSVTSWLAGCGTELP	PKHD1	741	P08F94
FLSEWITPEACTGPS	SLC25A48	201	Q6ZT89
QPSYETTILTECSPW	TFCP2L1	246	Q9NZI6
TTILTECSPWPDVAY	TFCP2L1	251	Q9NZI6
WPSSLGITDCCQYVT	ANGEL1	481	Q9UNK9
GWRNYTSCTVTCPPN	TECTA	1361	O75443
CRVSSSPAPAVSWLY	NCAM2	136	O15394
VLWKPGDSRAPCTYT	SPEG	2696	Q15772
WGPVTTYCHSLSPVE	STAG3	1046	Q9UJ98
SNWTGTCTIGYVTPD	ERVFRD-1	311	P60508
QPSYETTILTECSPW	TFCP2	266	Q12800
TTILTECSPWPEITY	TFCP2	271	Q12800
LDPLYPSRCSWETFG	TMEM94	1021	Q12767
PISSVERYDPAAGCW	KBTBD13	271	C9JR72
ESYLWNCPVSTLGAP	SCART1	401	Q4G0T1
TWTLCGTPEYLAPEV	PRKX	201	P51817
LGACVLSSPYDVPTW	PSME4	1766	Q14997
YLQPECSSSTDSPVW	ZMYM2	1326	Q9UBW7
DSSTTGPWCYTTDPT	F2	161	P00734
CSFSYPRQDWTGSTP	SIGLEC10	41	Q96LC7
CSSSEGAPKPVYNWV	VSIG2	166	Q96IQ7
PGYVVPCNCTAWSAS	SOX14	196	O95416
STCTWYLGTSGIQPV	TM7SF3	106	Q9NS93
PASWVEICSCPTGYT	LAMC3	666	Q9Y6N6
GDWSPLETTYPQTAC	LPIN2	226	Q92539
CTAEGSPAPSVTWDT	NECTIN4	171	Q96NY8